21:45:42 EDT Tue 04 Oct 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tilray Inc
Symbol TLRY
Shares Issued 446,156,841
Close 2021-12-01 C$ 11.87
Recent Sedar Documents

Tilray's Aphria launches medical pot oral strips

2021-12-02 09:12 ET - News Release

Mr. Irwin Simon reports

LAUNCH OF TILRAYA S FAST-ACTING ORAL STRIPS HIGHLIGHTS COMMITMENT TO MEDICAL CANNABIS INNOVATION AND PATIENT CARE

Tilray Inc.'s medical subsidiary, Aphria, has launched medical cannabis oral strips in THC and CBD-rich varieties. Powered by QuickStrip's proprietary technology, each Aphria medical strip contains a thin, edible film that contains rapidly dissolving, micronized cannabinoids that absorb directly into the bloodstream, providing patients with a fast-acting, convenient and precise dosing experience for relief from a range of conditions.

Irwin D. Simon, Tilray's chairman and chief executive officer, said: "Tilray's medical brands, Aphria, Symbios and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation and the earned trust of the medical community. The launch of the Aphria-branded medical strips is a compelling proof point in this regard, and, given the growing expansion of medical cannabis across the globe, we believe we are exceptionally well-positioned in this high-growth, high-margin market moving forward. We look forward to extending our leadership in medical cannabis and to delivering value for patients and shareholders alike."

Blair MacNeil, president at Tilray Canada, added: "At Aphria Medical, our goal is to be the trusted partner for patients by providing them with high-quality, precise and efficacious medical cannabis treatment. Delivering on this mission means meeting patients 'where they are,' including those who are unable or reluctant to swallow medication or do not prefer the taste of cannabis oil. To address this need, Aphria has pioneered a superior, non-combustible, discreet and easy-to-use method of consumption that utilizes micronized cannabinoids for rapid absorption and relief from a range of conditions."

The strips, which are now available throughout Canada, are available in three different cannabis ratios: THC 10, CBD 20:1 and THC:CBD 10:10 (coming soon). Each pack of Aphria oral strips comes with 30 individually wrapped strips for precise, single-dose delivery.

About Tilray Inc.

Tilray is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is changing people's lives for the better one person at a time by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of well-being. Tilray's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and alcoholic beverages.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.